Clinical Trial Update: Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J

View source ↗

Summary

Clinical trial update on the use of arsenic trioxide in young patients with leukemia or lymphoma treated on NCI-00-C-0070J.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Leukemia, Lymphoma | Status: COMPLETED